Latest Articles
Research Challenges Menstrual Taboo, Promotes Inclusion - Mirage News
Research Challenges Menstrual Taboo, Promotes Inclusion Mirage News
Published: Nov. 27, 2025, 12:18 p.m.
Monmouth floods prompts 'danger to life' warnings and evacuations - BBC
Monmouth floods prompts 'danger to life' warnings and evacuations BBC
Published: Nov. 15, 2025, 7:24 a.m.
Monmouth floods prompt 'danger to life' warnings and evacuations - BBC
Monmouth floods prompt 'danger to life' warnings and evacuations BBC
Published: Nov. 15, 2025, 7:24 a.m.
FDA approves Promega’s OncoMate test to guide personalised treatment for endometrial cancer - Indian Pharma Post
FDA approves Promega’s OncoMate test to guide personalised treatment for endometrial cancer Indian Pharma Post
Published: Nov. 14, 2025, 3:26 p.m.
Promega wins FDA approval as companion diagnostic for Keytruda-Lenvima combo in uterine cancer - Fierce Biotech
Promega wins FDA approval as companion diagnostic for Keytruda-Lenvima combo in uterine cancer Fierce Biotech
Published: Nov. 13, 2025, 9 a.m.
FDA Approves Promega OncoMate® MSI Dx as Companion Diagnostic for KEYTRUDA® and LENVIMA® in Endometrial Cancer - Voice Of HealthCare
FDA Approves Promega OncoMate® MSI Dx as Companion Diagnostic for KEYTRUDA® and LENVIMA® in Endometrial Cancer Voice Of HealthCare
Published: Nov. 13, 2025, 6:17 a.m.
FDA Approves Promega OncoMate® MSI Dx Analysis System as Companion Diagnostic for KEYTRUDA® in Combination with LENVIMA® In Advanced Endometrial Carcinoma - 뉴스와이어
FDA Approves Promega OncoMate® MSI Dx Analysis System as Companion Diagnostic for KEYTRUDA® in Combination with LENVIMA® In Advanced Endometrial Carcinoma 뉴스와이어
Published: Nov. 13, 2025, 5:50 a.m.
FDA Approves Promega OncoMate® MSI Dx Analysis System as Companion Diagnostic for KEYTRUDA® in Combination with LENVIMA® In Advanced Endometrial Carcinoma - BioSpace
FDA Approves Promega OncoMate® MSI Dx Analysis System as Companion Diagnostic for KEYTRUDA® in Combination with LENVIMA® In Advanced Endometrial Carcinoma BioSpace
Published: Nov. 12, 2025, 4:01 a.m.
Chrisley Knows Best: Savannah Chrisley Slammed For Promoting Weight-Loss Drugs?! - TV Season & Spoilers
Chrisley Knows Best: Savannah Chrisley Slammed For Promoting Weight-Loss Drugs?! TV Season & Spoilers
Published: Nov. 11, 2025, 4:21 p.m.
Proteomics International Laboratories Ltd (ASX:PIQ) PromarkerEndo Test for Endometriosis Receives $0.5m Grant - ABN Newswire
Proteomics International Laboratories Ltd (ASX:PIQ) PromarkerEndo Test for Endometriosis Receives $0.5m Grant ABN Newswire
Published: Nov. 6, 2025, 3:51 a.m.
Link copied to clipboard!